ICD-10-CM 2027 diagnosis code
D22.2Melanocytic nevi of ear and external auricular canal
D22.2 is a header code, so it can't be reported by itself. Choose one of the 3 more specific codes beneath it.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About D22.2
D22.2 is the ICD-10-CM diagnosis code for Melanocytic nevi of ear and external auricular canal. It belongs to category D22 (Melanocytic nevi), block D10-D36 (benign neoplasms, except benign neuroendocrine tumors) and chapter 2 (neoplasms). It is a header code, so it can't be reported by itself; one of its 3 subcodes must be used instead.
Within D22 (Melanocytic nevi), D22.2 is specifically for Melanocytic nevi of ear and external auricular canal. Related codes cover of lip (D22.0), of eyelid, including canthus (D22.1), of other and unspecified parts of face (D22.3), of scalp and neck (D22.4), of trunk (D22.5), of upper limb, including shoulder (D22.6), of lower limb, including hip (D22.7) and unspecified (D22.9).
To report this condition, pick the subcode that matches the documentation: D22.20 (canal), D22.21 (canal) and D22.22 (canal).
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Specific codes under D22.2
Notes that apply from higher levels
Instructions written at a parent level also apply to D22.2.
› From D22 Melanocytic nevi
- atypical nevus
- blue hairy pigmented nevus
- nevus NOS
Broader instructions also apply from Chapter 2: Neoplasms.
Alphabetic index entries
7 entriesTerms in the official ICD-10-CM index that lead to D22.2.
Codes whose notes reference D22.2
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about D22.2
Is D22.2 billable?
- No. D22.2 is a header code. Report one of its more specific subcodes instead.